🟢 Intellia Therapeutics is trading 6.69% up today in after-hours trading

Intellia Therapeutics is trading at $12.97, up 6.69% in after-hours trading, with no confirmed company-specific catalyst.

• No new Intellia Therapeutics-specific announcement was identified on September 24, 2026.
• Anthropic’s Claude identified an unproven CRISPR-like enzyme system, pressuring gene-editing stocks earlier. Its biological function and therapeutic relevance remain unknown, so it does not clearly explain the gain.
• The Nasdaq was down 1.07%; a company-specific or trading-related move remains unconfirmed.